TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05478642

Intervention type: OTHER
Intervention: The Hospital Anxiety and Depression Scale.
Description: The study was carried out on the basis of the National Military Medical Clinical Center Main Military Clinical Hospital. All patients participated in Operation Joint Forces and received gunshot wounds during combat operations.~A retrospective analysis of disease histories for the period from 2014 to 2021 was carried out. Data collection was carried out at all stages of treatment: medical and nursing brigade, military mobile hospital, military medical clinical center, during rehabilitation, within 12 months of the injury.~Recruitment of patients for the prospective study was carried out in the period from 02.24.2022 to 05.24.2022. Data collection was carried out during the Russian invasion of Ukraine and the offensive on Kyiv.

Intervention type: OTHER
Intervention: The Hospital Anxiety and Depression Scale.
Description: The study was carried out on the basis of the National Military Medical Clinical Center Main Military Clinical Hospital. All patients participated in Operation Joint Forces and received gunshot wounds during combat operations.~A retrospective analysis of disease histories for the period from 2014 to 2021 was carried out. Data collection was carried out at all stages of treatment: medical and nursing brigade, military mobile hospital, military medical clinical center, during rehabilitation, within 12 months of the injury.~Recruitment of patients for the prospective study was carried out in the period from 02.24.2022 to 05.24.2022. Data collection was carried out during the Russian invasion of Ukraine and the offensive on Kyiv.
Study: NCT06051669

Intervention type: DEVICE
Intervention: iLivTouch
Description: The examination with iLivTouch will be performed in each subject following the sequence determined by the randomization results.

Intervention type: DEVICE
Intervention: iLivTouch
Description: The examination with iLivTouch will be performed in each subject following the sequence determined by the randomization results.

Intervention type: DEVICE
Intervention: FibroScan
Description: The examination with FibroScan will be performed in each subject following the sequence determined by the randomization results.

Intervention type: DEVICE
Intervention: FibroScan
Description: The examination with FibroScan will be performed in each subject following the sequence determined by the randomization results.
Study: NCT05684458

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reiki
Description: Reiki, a non-invasive, free and safe complementary therapy method, is practiced with a series of hand positions held on the patient's body to help balance the life force energy.
Study: NCT06097065

Intervention type: DIAGNOSTIC_TEST
Intervention: Oral Glucose Tolerance Test
Description: Grouping based on detected oral glucose tolerance test results without any other intervention.

Intervention type: DIAGNOSTIC_TEST
Intervention: Oral Glucose Tolerance Test
Description: Grouping based on detected oral glucose tolerance test results without any other intervention.

Intervention type: DIAGNOSTIC_TEST
Intervention: Oral Glucose Tolerance Test
Description: Grouping based on detected oral glucose tolerance test results without any other intervention.

Intervention type: DIAGNOSTIC_TEST
Intervention: Oral Glucose Tolerance Test
Description: Grouping based on detected oral glucose tolerance test results without any other intervention.
Study: NCT04851912

Intervention type: OTHER
Intervention: Winterlight Apps
Description: Longitudinal speech recordings
Study: NCT05682339

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quinine
Description: Quinine, which is a bitter compound, extracted from the bark of the cinchona tree and has been shown in our previous studies to lower blood glucose in doses of 300-600 mg, will be 'active' in this condition.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: L-isoleucine
Description: L-isoleucine, which is a branched-chain amino acid, and one of the building blocks of protein, therefore is part of our daily diet, will be 'active' in this condition.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Combination of quinine and L-isoleucine
Description: In this condition, both quinine and L-isoleucine will be administered as 'active'.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: In the condition, where quinine is 'active', control for L-isoleucine (5 ml oraplus and 95 ml saline) will be administered. In the condition, where L-isoleucine will be 'active', control for quinine (10 ml distilled water) will be administered.~Whereas, in a control condition, both for quinine and L-isoleucine, a control solution will be administered.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: In the condition, where quinine is 'active', control for L-isoleucine (5 ml oraplus and 95 ml saline) will be administered. In the condition, where L-isoleucine will be 'active', control for quinine (10 ml distilled water) will be administered.~Whereas, in a control condition, both for quinine and L-isoleucine, a control solution will be administered.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: In the condition, where quinine is 'active', control for L-isoleucine (5 ml oraplus and 95 ml saline) will be administered. In the condition, where L-isoleucine will be 'active', control for quinine (10 ml distilled water) will be administered.~Whereas, in a control condition, both for quinine and L-isoleucine, a control solution will be administered.
Study: NCT04934566

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ECMO flow
Description: Dynamic changes in ECMO flow and SvO2 measurement at the 3 different sites.
Study: NCT05737472

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High-protein RUTF
Description: The high-protein RUTF is isocaloric to the standard RUTF. To have a higher protein quantity and quality, the recipe has greater proportions of milk powder plus whey protein and vegetable oil. A total of 15% of energy is from protein. The protein quality score, digestible indispensable amino acid score (DIAAS )of the high protein, RUTF is 1.18 which is equivalent to a Protein Digestibility Corrected Amino Acid Score (PDCAAS) of 1.19

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Standard RUTF
Description: The standard RUTF was manufactured according to WHO recommendations, with at least 50% of protein-sourced dairy, mainly skim milk. A total of 10% of energy is from protein. The protein quality score, digestible indispensable amino acid score (DIAAS) of the standard RUTF is 0.76, which is equivalent to a Protein Digestibility Corrected Amino Acid Score (PDCAAS) of 0.86.
Study: NCT06362954

Intervention type: OTHER
Intervention: Assessment
Description: Chedoke-McMaster Stroke Assessment (CMSA), Modified Ashworth Scale (MAS), Near-Infrared Spectroscopy (NIRS), 6-Minute Walk Test (6MWT), Stair Climbing Test (SCT), Adipose Tissue Thickness

Intervention type: OTHER
Intervention: Assessment
Description: Chedoke-McMaster Stroke Assessment (CMSA), Modified Ashworth Scale (MAS), Near-Infrared Spectroscopy (NIRS), 6-Minute Walk Test (6MWT), Stair Climbing Test (SCT), Adipose Tissue Thickness
Study: NCT05594862

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Lipogems
Description: Micro-fragmented adipose tissue infiltration
Study: NCT04763499

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: freeze dried strawberry powder
Description: approximately 24 strawberries that have been freeze dried into a powder

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: freeze dried strawberry powder
Description: approximately 24 strawberries that have been freeze dried into a powder
Study: NCT04777890

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: suboccipital inhibition
Description: The therapist will seat at the patient's head height and place his second, third, fourth and fifth fingertips'over the patient's suboccipital area during a 10-minute period.
Study: NCT05679570

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Satralizumab (Genetical Recombination)
Description: Efficacy Evaluation Period:~The study drug will be administered at a dose of 120 mg subcutaneously at initial, 2-week, 4-week, and 4-week intervals thereafter. Efficacy will be assessed after 24 weeks of study drug administration. Subjects who demonstrate efficacy and wish to continue treatment will receive the study drug for 24 weeks and moving to the continuous treatment period. In all other cases, the study will be terminated after 24 weeks of the efficacy evaluation period without the administration of study drug.~Continuation Dosing Period\[1\]:~Subjects who demonstrate efficacy during the efficacy evaluation period and wish to continue will receive continued 28 weeks (52 weeks total) treatment with satralizumab.~Continuation Dosing Period\[2\]:~Subjects completed continuation dosing period\[1\], clinically capable of continued administration, and wish to continue will receive continued treatment with satralizumab until the end of this study period.
Study: NCT04777890

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: INYBI
Description: The therapist will place the INYBI at the suboccipital area, specifically placing the fingers of the instrument at the lower border of the occipital. If needed, a rolled towel will be placed behind the INYBI, in order to maintain the physiological lordosis, checking out that the patient doesn't make a cervical extension. Then the therapist will press the vibration button and turn it off after 10 minutes. All patients will receive the treatment with the INYBI's hardest head with a 50 HZ frequency.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: INYBI + upper cervical manipulation
Description: The participant will also be treated with the INYBI during a 10-minute period. After that, the therapist will carry out the upper cervical manipulation technique. Keeping the patient's head on an upper cervical flexion position, the therapist will turn his/her head to the maximum possible rotation, always maintaining its longitudinal axis. Once this is done, a high velocity and short articular amplitude manipulation in rotation will be carried out
Study: NCT06355869

Intervention type: OTHER
Intervention: repeated 3D gait-analysis
Description: An observational 3D gait-analysis was performed with a period of 1-14 days is foreseen between the two measurements.
Study: NCT05886166

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: robot assisted training
Description: Rebless® (H-ROBOTICS, KOREA) is a knee or ankle robot for range of motion (ROM) and strength training that can operate in passive or active mode in knee or ankle flexion and extension. The patients underwent 30 min of robot training using Rebless® with 30 min conventional therapy, 5 days a week for 8 weeks.
Study: NCT05526872

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Practice
Description: Receive usual care

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive usual care

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Education
Description: Receive educational materials

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interview
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Planned Notification
Description: Receive planned reminders to schedule mammogram

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey Administration
Description: Ancillary studies
Study: NCT04908254

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Crossover Device (PCD or Dayspring - alternate to first group)
Description: Cross over arms after a month of use and a month of washout period

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Crossover Device (PCD or Dayspring - alternate to first group)
Description: Cross over arms after a month of use and a month of washout period
Study: NCT05255458

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AK102
Description: Administered AK102 by subcutaneous injection Drug: Statins and/or Ezetimibe lipid-lowering therapies

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered placebo by subcutaneous injection Drug: Statins and/or Ezetimibe lipid-lowering therapies
Study: NCT06205940

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Audioguided Nature tour
Description: Listening to audio instructions by an app while visiting nature. The instructions emphasize the connection between self and nature and direct attention to the present moment experience by guiding focus towards sensory experiences and specific natural elements.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Non audio guided nature tour
Description: Visiting nature without listening to audio instructions by an app
Study: NCT06397001

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nL-SAA1-01
Description: Personalized antisense oligonucleotide
Study: NCT05258136

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: low-dose CD20 monoclonal antibody injection
Description: To comprehend the efficacy and safety of low-dose CD20 monoclonal antibody injection in preemptive treatment of EBV positive lymphoproliferative diseases after allo-HSCT in patients with EBV-HLH and CAEBV
Study: NCT05622604

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: pray.com app (autonomous use)
Description: Participants will be given a free subscription to the Pray.com app and will be directed to use the app five days per week.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: pray.com app (meditative prayer condition)
Description: Participants will be given a free subscription to the Pray.com app and will be directed to listen to a meditation prayer five days per week.
Study: NCT05184192

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin gelatin capsules 300mg
Description: Gabapentin is an anti-epileptic also used for nerve pain. This study will investigate the efficacy of gabapentin for olfactory nerve recovery and improvement in post-Covid-19 olfactory dysfunction.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: lactose monohydrate NF
Study: NCT06345547

Intervention type: OTHER
Intervention: ultrasound
Description: Ultrasound of m. quadriceps and m. thenar All ultrasound measurements will be performed in triplicate, with the average of the scores used in final analyses. Four parameters will be evaluated: muscle thickness, muscle cross sectional area, pennation angle and echo intensity (gain, depth and frequency will be kept constant).~Hand grip strength measurement: measurement by an electronic hand dynamometer DynEx1TM (MD Systems, Inc. Ohio, USA). The recommendations for the handgrip strength test of the American Society of Hand Therapists will be followed: The maximum of the three values will be considered for analysis.

Intervention type: OTHER
Intervention: ultrasound
Description: Ultrasound of m. quadriceps and m. thenar All ultrasound measurements will be performed in triplicate, with the average of the scores used in final analyses. Four parameters will be evaluated: muscle thickness, muscle cross sectional area, pennation angle and echo intensity (gain, depth and frequency will be kept constant).~Hand grip strength measurement: measurement by an electronic hand dynamometer DynEx1TM (MD Systems, Inc. Ohio, USA). The recommendations for the handgrip strength test of the American Society of Hand Therapists will be followed: The maximum of the three values will be considered for analysis.

Intervention type: OTHER
Intervention: ultrasound
Description: Ultrasound of m. quadriceps and m. thenar All ultrasound measurements will be performed in triplicate, with the average of the scores used in final analyses. Four parameters will be evaluated: muscle thickness, muscle cross sectional area, pennation angle and echo intensity (gain, depth and frequency will be kept constant).~Hand grip strength measurement: measurement by an electronic hand dynamometer DynEx1TM (MD Systems, Inc. Ohio, USA). The recommendations for the handgrip strength test of the American Society of Hand Therapists will be followed: The maximum of the three values will be considered for analysis.
Study: NCT04733950

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Forced choice psychoacoustic task for the evaluation of modulation detection performance and selective auditory attention. (for both arm)
Description: Description:~3-interval, 3-alternative forced choice amplitude modulation detection task using a target sinusoidal carrier and a spectrally distant, interfering (distracting), sinusoidal carrier that may or not be modulated at the same rate as the target.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Forced choice psychoacoustic task for the evaluation of modulation detection performance and selective auditory attention. (for both arm)
Description: Description:~3-interval, 3-alternative forced choice amplitude modulation detection task using a target sinusoidal carrier and a spectrally distant, interfering (distracting), sinusoidal carrier that may or not be modulated at the same rate as the target.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Measurement of the pupil diameter for the evaluation of listening effort during speech perception
Description: Pupil diameter is recorded using an eye-tracker device (Tobii Pro TX300) while the subject performs a 16-alternative consonant identification task both in silence and in the presence of interfering speech.
Study: NCT05863325

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HB1801
Description: HB1801 will be administered by intravenous (IV) injections on the first day of each cycle.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Taxotere
Description: Taxotere will be administered by intravenous (IV) injections on the first day of each cycle.
Study: NCT05101057

Intervention type: DEVICE
Intervention: SpinalogicTM Bone Graft Stimulator
Description: The SpinalogicTM is a portable, battery-powered, microprocessor-controlled, non-invasive bone growth stimulator. The device is currently approved and commercially indicated as an adjunct electrical treatment to primary lumbar spinal fusion surgery for one or two levels.
Study: NCT05237674

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The TEACHOUT intervention
Description: The core component of the Intervention is a two-day training course on EOtC given to elementary school teachers followed by the teachers committing to apply EOtC for at least five hours a week, delivered in 1-2 weekly sessions for one school year (in this study, August 2022 to June 2023).~In the training course knowledge and understanding of the practice and theory of EOtC is facilitated in presentations and talks supplemented by illustrative examples in workshops and plenum discussions on local implementation. The 1-2 weekly EOtC sessions during the school year 2022-2023 may be delivered by one or more teachers simultaneously in various school subjects, at various places outside the school buildings.
Study: NCT05992207

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: motor imaginary training
Description: Each child shown a video of 5 minutes of illustrating normal movements while the child resting in semi#reclined sitting in quiet room in front the screen. Children then asked to close their eyes and imagine practicing the task like the illustrative video. Repetition of the exercises depend on the children ranging from 5 to 10 repetitions per exercise.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: physical therapy training
Description: facilitation of balance and protective reactions from standing position, standing on one leg, weight shifting from standing, squat to standing, strengthening exercises for trunk muscles and for upper and lower extremities musculatures, gait training activities for correction of gait pattern
Study: NCT06282029

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group Therapy
Description: Acceptance and Commitment Therapy based group therapy
Study: NCT04733950

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measurement of the pupil diameter for the evaluation of listening effort during speech perception
Description: Pupil diameter is recorded using an eye-tracker device (Tobii Pro TX300) while the subject performs a 16-alternative consonant identification task both in silence and in the presence of interfering speech.
Study: NCT05971732

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferric derisomaltose
Description: After baseline assessments patients will be randomised in a 1:1 ratio to receive ferric derisomaltose IV or placebo (normal saline). In the Treatment group, Ferric derisomaltose will be administered according to the dosing schedule.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: In the placebo group, patients will receive the equivalent number of normal saline injections.
Study: NCT06539078

Intervention type: OTHER
Intervention: Maximal exercise test
Description: Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.

Intervention type: OTHER
Intervention: Maximal exercise test
Description: Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.
Study: NCT06279455

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle Exercise
Description: A 12-week pelvic floor muscle exercise program was applied to pregnant women.
Study: NCT05120414

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: balanace exercises
Description: Balance exercises included standing with feet together (narrow base of support), Standing in Tandem position, Standing eye open to eye closed, multidirectional functional reach during standing, March in place and walk sideways. Time period was of 4 weeks (10 repetitions in each set, 3 sets per session, 1 session daily, 3 days weekly).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance Exercises plus Ankle strategy
Description: ankle strategy exercises included raising and lowering heels and forefeet, heel to toe walking, stepping up and down and right and left and diagonal inclination of body during standing.While balance exercises included standing with feet together (narrow base of support), Standing in Tandem position, Standing eye open to eye closed, multidirectional functional reach during standing, March in place and walk sideways. Time period was of 4 weeks (10 repetitions in each set, 3 sets per session, 1 session daily, 3 days weekly).
Study: NCT02777762

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fun First
Description: 8 weekly interactive small-group sessions with a health coach

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Close at Hand
Description: 8 weekly check-ins with a state of the art, engaging mobile app